Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

UnitedHealth Group Posts Q2 Revenue Gain


UnitedHealth Group (NYSE:UNH), a leading diversified healthcare and insurance provider, reported results for the second quarter of fiscal 2025 on July 29, 2025. The most significant news was its earnings disappointment: adjusted earnings per share (non-GAAP) came in at $4.08, well below the $4.48 analyst consensus, while revenue (GAAP) was $111.6 billion -- slightly above the $111.5 billion projection.

Even with robust revenue growth, UnitedHealth Group's profitability was weighed down by higher medical costs and a steep drop in operating margins, driven in part by unusually high utilization in its Medicare business earlier in the year and industrywide regulatory headwinds. Overall, the period highlighted strong top-line momentum alongside both operational and margin pressures, with management citing a path to stabilization and renewed growth in 2026.

Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report.

Continue reading


Source Fool.com

UnitedHealth Group Inc. Stock

€348.40
-1.640%
A loss of -1.640% shows a downward development for UnitedHealth Group Inc..
The stock is one of the favorites of our community with 76 Buy predictions and 2 Sell predictions.
As a result the target price of 366 € shows a slightly positive potential of 5.05% compared to the current price of 348.4 € for UnitedHealth Group Inc..
Like: 0
UNH
Share

Comments